Ongoing Therapy Monitoring Blood Panel

Regular blood testing is built into every hormone therapy programme at Advanced TRT Clinic San Francisco, with follow-up panels scheduled at defined intervals to ensure safety and therapeutic efficacy. Monitored markers include haematocrit, PSA, liver enzymes, and a full metabolic profile alongside hormone levels. Results are reviewed by a specialist who adjusts dosage as needed, serving Bay Area patients from Oakland, Berkeley, Emeryville, and Daly City.

Ongoing blood testing is a non-negotiable component of every therapy protocol at Advanced TRT Clinic San Francisco. Unlike one-time wellness checks, the monitoring cadence at this clinic is integrated directly into the treatment management cycle — making it one of the most medically rigorous aspects of the programme and a key differentiator from subscription-based telehealth TRT services that rarely follow up with structured labs. For patients on testosterone replacement therapy, the standard monitoring schedule involves blood draws at approximately 6 weeks after initiating therapy, again at 3 months, and then every 6 months once levels have stabilised. The markers tracked at each interval go well beyond testosterone itself: haematocrit is measured because exogenous testosterone stimulates red blood cell production and elevated haematocrit increases clotting risk; PSA (prostate-specific antigen) is monitored as a baseline safety check for patients over 40; and liver function tests (ALT, AST, bilirubin) are included because some injectable agents warrant hepatic monitoring. Patients undergoing HGH therapy receive additional panel coverage for IGF-1 (to confirm the therapeutic range and avoid supraphysiological levels), fasting glucose, and insulin markers — since growth hormone can transiently reduce insulin sensitivity. Peptide therapy patients may have lighter panel requirements depending on the peptide sequence, though BPC-157 and Sermorelin protocols still involve periodic liver and glucose checks. All blood work is reviewed by a physician or nurse practitioner who communicates results and any dosage adjustments directly to the patient. The Financial District suite at 50 California Street is accessible from throughout San Francisco and the wider Bay Area, with public transit connections from Oakland, Berkeley, and Emeryville making it convenient for patients across the region who want structured, evidence-based hormone health management.